SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-17-000665
Filing Date
2017-08-23
Accepted
2017-08-23 10:14:41
Documents
2
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss55997_sc13da.htm SC 13D/A 125679
2 JOINT FILING AGREEMENT ss55997_ex9901.htm EX-99.1 25682
  Complete submission text file 0000947871-17-000665.txt   152898
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 20 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address 20 INDEPENDENCE BOULEVARD WARREN NJ 07059 908-605-4700
Roka BioScience, Inc. (Subject) CIK: 0001472343 (see all company filings)

IRS No.: 270881542 | State of Incorp.: DE | Fiscal Year End: 1216
Type: SC 13D/A | Act: 34 | File No.: 005-88250 | Film No.: 171046382
SIC: 3826 Laboratory Analytical Instruments